TAM
AXSM icon

TFG Asset Management’s Axsome Therapeutics AXSM Stock Holding History

TFG Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,059
Closed -$4.35M – 40
2026
Q1 		$3.39M Sell
20,059
-6,875
-26% -$1.19M 0.66% 24
2025
Q4 		$4.92M Sell
26,934
-19,522
-42% -$2.73M 1.04% 12
2025
Q3 		$5.64M Buy
46,456
+4,925
+12% +$555K 0.75% 19
2025
Q2 		$4.34M Buy
41,531
+7,725
+23% +$818K 0.7% 20
2025
Q1 		$3.94M Sell
33,806
-7,444
-18% -$848K 0.9% 17
2024
Q4 		$3.49M Buy
+41,250
New +$3.79M 0.89% 19

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TFG Asset Management's AXSM Position: Q2 2026 in Review

TFG Asset Management sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 20,059 shares — an estimated $4.35M sold.

TFG Asset Management first reported a position in AXSM in Q4 2024 and held it in 6 quarters. The position peaked at $5.64M in Q3 2025. 505 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • TFG Asset Management reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
  • TFG Asset Management sold 20,059 Axsome Therapeutics shares in Q2 2026, an estimated $4.35M.
  • TFG Asset Management first reported a position in Axsome Therapeutics in Q4 2024 and held it in 6 quarters.
  • TFG Asset Management's Axsome Therapeutics position peaked at $5.64M in Q3 2025.
  • 505 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on TFG Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.